FERMT1 and central nervous system cancer: Transwell assays also demonstrated that FERMT1 deficiency markedly reduced the percentages of migrated and invasive cells compared to shNC cells, which characterized the role of FERMT1 in promoting cell metastasis in glioma (Fig. 2J and M).